MRI and Gene Expression Assay in DCIS

Open-label trial in ductal carcinoma in situ (DCIS) (5 arms), sponsored by ECOG-ACRIN Cancer Research Group. Primary endpoints: Proportion of patients judged to be breast conservation candidates who convert to mastectomy in step 1 based on MRI findings and Proportion of patients judged to be breast conservation candidates who have a mastectomy as the final surgical procedure in step 2 at 12 months. Started Mar 2015; status: active, not recruiting.